Therapix Biosciences

1 stories about Therapix Biosciences
קנאביס קנביס רפואי מריחואנה יצוא

Canada's FSD Pharma to Acquire Israeli Therapix Biosciences for $48 Million in Stock

23.10.18|Lilach Baumer
Clinical-stage Therapix Biosciences develops cannabinoid-based drugs for the treatment of neurological conditions, pain management, and infectious diseases
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1